Back

Results - Announcements

Sales rise 19.47% to Rs 2116.25 crore

Emcure Pharmaceuticals consolidated net profit rises 64.07% in the March 2025 quarter

22-May-2025, 03:16
Net profit of Emcure Pharmaceuticals rose 64.07% to Rs 188.96 crore in the quarter ended March 2025 as against Rs 115.17 crore during the previous quarter ended March 2024. Sales rose 19.47% to Rs 2116.25 crore in the quarter ended March 2025 as against Rs 1771.36 crore during the previous quarter ended March 2024.

For the full year,net profit rose 36.76% to Rs 681.33 crore in the year ended March 2025 as against Rs 498.18 crore during the previous year ended March 2024. Sales rose 18.59% to Rs 7896.00 crore in the year ended March 2025 as against Rs 6658.25 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	2116.25	1771.36	19	7896.00	6658.25	19
OPM %	19.02	17.58	-	18.67	18.47	-
PBDT	367.83	257.61	43	1365.86	1049.57	30
PBT	270.99	167.04	62	981.73	737.16	33
NP	188.96	115.17	64	681.33	498.18	37